Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Bruker (BRKRP) over the last 16 years, with Q3 2025 value amounting to $258.4 million.

  • Bruker's Cash from Financing Activities rose 967037.04% to $258.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.7 million, marking a year-over-year decrease of 8170.94%. This contributed to the annual value of $1.2 billion for FY2024, which is 73588.42% up from last year.
  • Per Bruker's latest filing, its Cash from Financing Activities stood at $258.4 million for Q3 2025, which was up 967037.04% from $95.5 million recorded in Q2 2025.
  • Over the past 5 years, Bruker's Cash from Financing Activities peaked at $1.2 billion during Q2 2024, and registered a low of -$217.4 million during Q1 2022.
  • Over the past 5 years, Bruker's median Cash from Financing Activities value was -$36.1 million (recorded in 2022), while the average stood at $65.4 million.
  • As far as peak fluctuations go, Bruker's Cash from Financing Activities tumbled by 305384.62% in 2022, and later soared by 1132135.92% in 2024.
  • Quarter analysis of 5 years shows Bruker's Cash from Financing Activities stood at $404.3 million in 2021, then tumbled by 108.93% to -$36.1 million in 2022, then crashed by 65.93% to -$59.9 million in 2023, then dropped by 25.21% to -$75.0 million in 2024, then surged by 444.53% to $258.4 million in 2025.
  • Its last three reported values are $258.4 million in Q3 2025, $95.5 million for Q2 2025, and -$51.2 million during Q1 2025.